Pharmaceutical

Pfizer boasts over 30% increase in Q3 revenues against previous year

Amidst a share value slump and executive turmoil, Pfizer reported a robust quarter thanks in part to Covid-19 drug sales.

Nov 1, 2024 - 04:00
Pfizer boasts over 30% increase in Q3 revenues against previous year
Amidst a share value slump and executive turmoil, Pfizer reported a robust quarter thanks in part to Covid-19 drug sales.
Read the original article

Tags:

Previous Article

Will the tide turn for the wave of pharma layoffs?

Next Article

For pharma companies, the possibilities of green chemistry are huge

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Here’s what’s moving the needle in biotech stocks, in the final quarter of a dismal year

Here’s what’s moving the needle in biotech stocks, in t...

Oct 2, 2023

Roche Canada and pCPA conclude talks for Vabysmo eye therapy

Roche Canada and pCPA conclude talks for Vabysmo eye th...

May 30, 2023

STAT+: Pharmalittle: Exec nominated to Biogen board is mother of outgoing director’s child; telehealth company pauses Wegovy ads amid shortages

STAT+: Pharmalittle: Exec nominated to Biogen board is ...

Jun 14, 2023